🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 92337F107
- Market Cap
- Large Cap
- IPO
- 11/4/2013 · $13.00/share
Business: Veracyte, Inc. is focused on discovering, developing and commercializing molecular cytology solutions that enable physicians to make more informed treatment decisions at an early stage in patient care, thus helping patients avoid unnecessary invasive procedures while reducing healthcare costs. Veracyte's first commercial solution, the Afirma Thyroid FNA Analysis, includes the Gene Expression Classifier.
Company Contact
- CEO
- Marc Stapley
- CFO
- Rob Brainin
- Headquarters
- 6000 Shoreline Court, Suite 300, South San Francisco, CA 94080
- Phone
- 650-243-6300
- Fax
- 650-243-6301
- Investor Relations
- Tracy Morris · 650-380-4413 · tracy.morris@veracyte.com